Clinical OMICS

JAN-FEB 2018

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link:

Contents of this Issue


Page 49 of 51 January/February 2018 Clinical OMICs 48 Industry Events Molecular Medicine Tri-Con San Francisco, February 11-16 Join more than 3,700 drug discovery and development pro- fessionals in San Francisco. Now in its 25th year, the Inter- national Molecular Medicine Tri-Conference (Molecular Tri-Con) attracts drug discovery and development profes- sionals from more than 40 countries. Since its debut in 1993, the conference has become one of the world's leading inter- national events in the field of drug disco and diagnostics. Over the course of five d meeting features six parallel conference tracks, Symposia, and 25 in-depth short courses. Educational sessions include best practice case studies and joint partner presentations, featuring more than 500 industry and academic experts in the areas of cancer research, big data, molecular diagnos- tics, precision medicine, rare diseases, data science, human microbiome, point-of-care diagnostics, infectious diseases, and much more. Advances in Genome Biology and Technology (AGBT) Orlando, FL, February 12–15 Nearly 1,000 researchers from around the world will meet in Orlando, FL for Advances in Genome Biology and Tech- nology (AGBT). As a recognized cornerstone for the genom- ics community, AGBT provides a forum for exchanging information about the latest advances in DNA sequencing technologies, experimental and analytical approaches for genomic studies, and their myriad applications. The meet- ing format includes daytime plenary sessions featuring invited speakers, and abstract-selected talks that highlight cutting-edge research across the broad genomics landscape. Concurrent evening sessions include experimental and computational approaches for effectively ut DNA sequencing technologies. Future of Genomic Medicine La Jolla, CA, March 1–2 Sponsored by the Scripps Translation Science Institute in collaboration with AAAS/Science Translational Medicine, the Future of Genomic Medicine will detail proven methods of using genomic knowledge to transform the daily practice of medicine. A unique feature of the conference is the pre- sentation of this information by patients, and how the appli- cation of genomics affect their medical sta Further perspective is provided by experts in genomics and the life sciences. This year 's conference will provide a focus on genomic editing in the treatment of disease, cancer, and in the practice of preventative medicine. Other topics will include cfDNA diagnostics, epigenetics, and genomic ana- lytics, with an overarching goal of using genomic knowl- edge to transform the practice of medicine and to make it more precise and individualized. Genomics of Rare Disease Cambridge, U.K., March 26–28 Held on the Wellcome Genome Campus, the Genomics of Rare Disease conference will examine ne genomic science and how cutting-edge genomic science informs our understanding of biology or rare diseases and its translation to the clinical setting. This year 's conference will highlight lessons learned from large-scale genome sequencing studies, while also shedding new light on mul- tiomic and single-cell technologies, and how they are con- tributing to a greater understanding of rare disease. Other topics of interest include new therapeutic approaches to rare disease, the development of bioinformatics tools for interpreting genomic data, and sessions on the legal and ethical issues surrounding the sharing of patient data. The multi-disciplinary forum will provide ben tion to clinicians, research and clinical scientists, bioinfor- maticians, and technology developers who are interested in learning of recent advances in genomics and technology that impact the care of patients with rare diseases. AF-studio / Getty Image

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - JAN-FEB 2018